Product Images Oxaliplatin
View Photos of Packaging, Labels & Appearance
- PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 100 mg Carton - oxali 100mg ns carton
- PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 100 mg Vial Label - oxali 100mg ns vial
- PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 50 mg Carton - oxali 50mg ns carton
- PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 50 mg Vial Label - oxali 50mg ns vial
- Figure 1 - oxali ns fig 1
- Figure 2 - oxali ns fig 2
- Figure 3 - oxali ns fig 3
- Structure - oxali ns structure
Product Label Images
The following 8 images provide visual information about the product associated with Oxaliplatin NDC 72603-420 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 100 mg Carton - oxali 100mg ns carton
This text provides information on Oxaliplatin, an injection for intravenous use only. It is a cytotoxic agent and must be diluted with 5% Dextrose Injection before use. The solution is preservative-free and comes in different dosages, such as 100 mg per 20 mL. The storage conditions, dosage, and administration instructions are also mentioned. Special caution is given not to dilute Oxaliplatin in sodium chloride containing solutions. For further information or in case of questions, contact the provided phone number.*
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 100 mg Vial Label - oxali 100mg ns vial
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 50 mg Carton - oxali 50mg ns carton
This text seems to be information about the medication "Oxaliplatin Injection, USP" in different variations (NDC 7260342041, NDC 7260342001), indicating the dosage in mg per 10 mL, its intravenous use, and precautions as a cytotoxic agent. The solution is described as sterile, preservative-free, and should be diluted with 5% Dextrose Injection. The text also includes administration instructions, storage conditions, contact information for inquiries, and a note about the container not being a reconstitution vial. Additional details about sodium chloride and single-dose vials are included. Please note that this can be used for informational purposes only and not as medical advice.*
PRINCIPAL DISPLAY PANEL – Oxaliplatin Injection, USP 50 mg Vial Label - oxali 50mg ns vial
This text appears to be a label for a medication called Oxaliplatin, presented as a Single-Dose Vial for Injection, USP. It is indicated for Intravenous Use Only. The label also includes the NDC (National Drug Code) number 72603-420-01. Please refer to the NDC number for further information or identification of this medication.*
Figure 1 - oxali ns fig 1
This text appears to be a list of numerical values, possibly related to a dataset or calculations. It includes elements like "arowon sou/uies @rin", "woee a0/ @Rim", and various numerical values such as 06, 05, 04, etc. It also mentions terms like "Logrank" and "Tomt" which could indicate some sort of statistical analysis or data comparison.*
Figure 2 - oxali ns fig 2
This description provides insights into DFS probability in relation to different stages and treatment arms in a clinical study. It mentions specific time points and factors like the DFS (months) and treatment arms FOLFOX4 and LVSFU2 for DUKES C stage patients. The information seems to be related to analyzing the effectiveness or outcomes of different treatment protocols.*
Figure 3 - oxali ns fig 3
Structure - oxali ns structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
